vs
Side-by-side financial comparison of LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) and TPG Mortgage Investment Trust, Inc. (MITT). Click either name above to swap in a different company.
LIFECORE BIOMEDICAL, INC. \DE\ is the larger business by last-quarter revenue ($31.1M vs $20.4M, roughly 1.5× TPG Mortgage Investment Trust, Inc.). TPG Mortgage Investment Trust, Inc. runs the higher net margin — 65.0% vs -32.1%, a 97.1% gap on every dollar of revenue. On growth, TPG Mortgage Investment Trust, Inc. posted the faster year-over-year revenue change (17.7% vs -4.5%). Over the past eight quarters, TPG Mortgage Investment Trust, Inc.'s revenue compounded faster (9.1% CAGR vs -0.1%).
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
TPG Mortgage Investment Trust, Inc. is a real estate investment trust managed by global alternative asset firm TPG. It primarily invests in residential and commercial mortgage-backed securities, performing and non-performing mortgage loans, and other credit-linked real estate assets, with its core market being the United States. It generates returns via net interest income from holdings and strategic asset disposition gains.
LFCR vs MITT — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $31.1M | $20.4M |
| Net Profit | $-10.0M | $13.3M |
| Gross Margin | 25.0% | — |
| Operating Margin | -9.9% | 67.1% |
| Net Margin | -32.1% | 65.0% |
| Revenue YoY | -4.5% | 17.7% |
| Net Profit YoY | -52.0% | -7.0% |
| EPS (diluted) | $-0.29 | $0.27 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $20.4M | ||
| Q3 25 | $31.1M | $19.5M | ||
| Q2 25 | — | $17.8M | ||
| Q1 25 | $35.2M | $18.8M | ||
| Q4 24 | $32.6M | $17.4M | ||
| Q3 24 | $24.7M | $14.9M | ||
| Q2 24 | — | $16.4M | ||
| Q1 24 | $35.7M | $17.2M |
| Q4 25 | — | $13.3M | ||
| Q3 25 | $-10.0M | $20.0M | ||
| Q2 25 | — | $3.9M | ||
| Q1 25 | $-14.8M | $11.5M | ||
| Q4 24 | $-6.6M | $14.3M | ||
| Q3 24 | $-16.2M | $16.6M | ||
| Q2 24 | — | $3.9M | ||
| Q1 24 | $15.6M | $20.9M |
| Q4 25 | — | — | ||
| Q3 25 | 25.0% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 28.0% | — | ||
| Q4 24 | 34.0% | — | ||
| Q3 24 | 21.8% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 33.3% | — |
| Q4 25 | — | 67.1% | ||
| Q3 25 | -9.9% | — | ||
| Q2 25 | — | 20.9% | ||
| Q1 25 | -25.7% | 54.6% | ||
| Q4 24 | -6.0% | 76.7% | ||
| Q3 24 | -46.9% | — | ||
| Q2 24 | — | 18.4% | ||
| Q1 24 | -2.5% | — |
| Q4 25 | — | 65.0% | ||
| Q3 25 | -32.1% | 102.5% | ||
| Q2 25 | — | 22.2% | ||
| Q1 25 | -42.0% | 60.9% | ||
| Q4 24 | -20.2% | 82.2% | ||
| Q3 24 | -65.7% | 111.3% | ||
| Q2 24 | — | 24.0% | ||
| Q1 24 | 43.8% | 121.6% |
| Q4 25 | — | $0.27 | ||
| Q3 25 | $-0.29 | $0.47 | ||
| Q2 25 | — | $-0.05 | ||
| Q1 25 | $-0.47 | $0.21 | ||
| Q4 24 | $-0.25 | $0.30 | ||
| Q3 24 | $-0.53 | $0.40 | ||
| Q2 24 | — | $-0.02 | ||
| Q1 24 | $0.42 | $0.55 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $18.9M | $57.8M |
| Total DebtLower is stronger | $136.0M | — |
| Stockholders' EquityBook value | $-10.5M | $560.7M |
| Total Assets | $235.2M | $8.7B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $57.8M | ||
| Q3 25 | $18.9M | $59.0M | ||
| Q2 25 | — | $88.7M | ||
| Q1 25 | $5.4M | $115.5M | ||
| Q4 24 | $9.5M | $118.7M | ||
| Q3 24 | — | $102.5M | ||
| Q2 24 | — | $120.9M | ||
| Q1 24 | — | $100.3M |
| Q4 25 | — | — | ||
| Q3 25 | $136.0M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $124.9M | — | ||
| Q4 24 | $111.3M | — | ||
| Q3 24 | $106.3M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $97.1M | — |
| Q4 25 | — | $560.7M | ||
| Q3 25 | $-10.5M | $559.8M | ||
| Q2 25 | — | $536.4M | ||
| Q1 25 | $2.2M | $543.9M | ||
| Q4 24 | $15.4M | $543.4M | ||
| Q3 24 | $-3.9M | $540.1M | ||
| Q2 24 | — | $533.5M | ||
| Q1 24 | $17.7M | $539.6M |
| Q4 25 | — | $8.7B | ||
| Q3 25 | $235.2M | $9.0B | ||
| Q2 25 | — | $7.5B | ||
| Q1 25 | $237.7M | $7.3B | ||
| Q4 24 | $255.4M | $6.9B | ||
| Q3 24 | $246.8M | $7.0B | ||
| Q2 24 | — | $7.1B | ||
| Q1 24 | $246.2M | $6.4B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 56.05× | — | ||
| Q4 24 | 7.20× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 5.49× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.8M | $59.6M |
| Free Cash FlowOCF − Capex | $25.0K | — |
| FCF MarginFCF / Revenue | 0.1% | — |
| Capex IntensityCapex / Revenue | 5.6% | — |
| Cash ConversionOCF / Net Profit | — | 4.48× |
| TTM Free Cash FlowTrailing 4 quarters | $-16.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $59.6M | ||
| Q3 25 | $1.8M | $17.4M | ||
| Q2 25 | — | $11.5M | ||
| Q1 25 | $1.2M | $12.0M | ||
| Q4 24 | $-6.1M | $55.8M | ||
| Q3 24 | $-613.0K | $14.5M | ||
| Q2 24 | — | $13.7M | ||
| Q1 24 | $-1.4M | $12.0M |
| Q4 25 | — | — | ||
| Q3 25 | $25.0K | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $-4.3M | — | ||
| Q4 24 | $-8.6M | — | ||
| Q3 24 | $-4.0M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $-7.8M | — |
| Q4 25 | — | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -12.1% | — | ||
| Q4 24 | -26.3% | — | ||
| Q3 24 | -16.3% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -21.8% | — |
| Q4 25 | — | — | ||
| Q3 25 | 5.6% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 15.5% | — | ||
| Q4 24 | 7.5% | — | ||
| Q3 24 | 13.9% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 17.8% | — |
| Q4 25 | — | 4.48× | ||
| Q3 25 | — | 0.87× | ||
| Q2 25 | — | 2.92× | ||
| Q1 25 | — | 1.05× | ||
| Q4 24 | — | 3.91× | ||
| Q3 24 | — | 0.87× | ||
| Q2 24 | — | 3.50× | ||
| Q1 24 | -0.09× | 0.57× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
MITT
Segment breakdown not available.
